Business Wire

AEVEX Achieves AS9100 Certification

Share

AEVEX Aerospace, a global leader in cutting-edge unmanned systems and services, is proud to announce it has been awarded the prestigious AS9100 certification for its Tampa, Florida facility. This internationally recognized standard provides the framework for developing and implementing quality management systems within the aviation, space, and defense industry. Achieved in just 9 months from official project launch, this certification further demonstrates the AEVEX commitment to delivering world-class products to the aerospace and defense markets.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250206206147/en/

AEVEX Aerospace achieves AS9100 certification, reinforcing its commitment to quality, innovation, and excellence in aerospace and defense. (Graphic: Business Wire)

AS9100, an industry-specific enhancement of ISO9001, establishes a set of robust quality management requirements to ensure the reliable delivery of safe, high-performance aerospace products. To achieve certification to this standard, AEVEX underwent rigorous evaluation by an industry recognized third party registrar. Each process and procedure were examined for a range of criteria, including resource identification, risk mitigation, quality planning, performance measurement/monitoring, and continuous improvement.

“This certification reflects a commitment to the quality of our work and the maturity of our organization,” said James “Mookie” Sturim, Senior Vice President. “As a company holding AS9100 certification, we look forward to expanding our differentiated, combat-proven product portfolios within the aerospace and defense sector, while continuing to provide the top-tier experience our customers have come to expect.”

About AEVEX Aerospace:

AEVEX Aerospace supports U.S. and partner nation security objectives by providing full-spectrum aviation and technology-based solutions. The company’s expanded capabilities include a wide variety of Unmanned Aircraft Systems (UAS), a combat-proven portfolio of loitering munitions, and a family of multi-mission Unmanned Surface Vehicles (USV). These additions complement AEVEX’s offerings in custom design & engineering, manned/unmanned aircraft modification & certification, sensor integration & sustainment, and other fielded solutions, including advanced intelligence analysis and tailored mission-system tools. AEVEX is headquartered in Solana Beach, California, with other major locations in Florida, Ohio, and Virginia. Learn more by visiting https://aevex.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250206206147/en/

Contacts

Press Contact:
Matt Gunn
Director of Marketing
mgunn@aevex.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Presidio Investors Welcomes Wynee Sade as Newest Operating Partner28.3.2025 17:32:00 EET | Press release

Presidio Investors is pleased to announce the addition of Wynee Sade as its newest Operating Partner. With over 25 years of global sales and marketing experience, Wynee has held senior leadership roles across a range of industries, including Chief Marketing Officer at Forager Project and leadership positions at Qooco, AppSymth, and Shopkick. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250327178560/en/ Wynee Sade, Presidio Investors Operating Partner Wynee’s expertise in driving growth, building brands, and leading high-performing teams has shaped organizations from early-stage startups to established Fortune 500 companies. She has a proven track record of scaling businesses and delivering impactful solutions. Wynee is also the founder of Yu Ming Charter School, California’s first public K-8 Mandarin immersion school, which has earned numerous accolades, including National Blue Ribbon recognition. Wynee holds an MBA from H

Join the 2025 Global Challenger Innovation Contest: Driving Inclusion Through Innovation28.3.2025 17:12:00 EET | Press release

The 10x1000 Tech for Inclusion community and next-generation corporate venture partner xcube.co launched the Global Challenger Innovation Contest 2025 at the JUMPSTARTER 2025 event in Hong Kong SAR, China, building on the success of the 2024 competition. Now in its second year, the contest continues to empower visionaries to create tech-driven solutions that promote inclusion and drive social impact. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250328955793/en/ 10x1000 Tech for Inclusion and xcube.co jointly launched the Global Challenger Innovation Contest in Hong Kong SAR, China, at the JUMPSTARTER 2025 event. The Global Challenger Innovation Contest was inaugurated in 2024 as a flagship project of 10x1000 Tech for Inclusion, a global initiative supported by the International Finance Corporation (IFC) and Ant International, to empower emerging tech leaders to create innovative solutions for financial inclusion and social

Altasciences Receives 2025 CDMO Leadership Award in Small Molecule Dosage Form Category28.3.2025 15:22:00 EET | Press release

Altasciences, a nine-time CRO Leadership Award winner, is proud to announce they have been awarded a 2025 CDMO Leadership Award in the Small Molecule Dosage Form–North America category. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250327305519/en/ Altasciences receives a 2025 CDMO Leadership Award in the Small Molecule Dosage Form (North America) category. Altasciences’ CDMO site supports drug development with formulation, manufacturing, and analytical testing—from discovery to commercialization. Their FDA-inspected facility features Grade C cleanrooms, R&D and analytical labs, ICH stability chambers, and a cGMP warehouse. "This recognition reflects our CDMO team’s unwavering dedication and expertise, as well as our unrelenting commitment to advancing drug development in collaboration with leading pharmaceutical and biotech innovators,” says Marie-Hélène Raigneau, Co-Chief Operating Officer at Altasciences. “We are gratefu

SES and SpeQtral Sign MoU to Advance Global Quantum-Secure Communications28.3.2025 14:49:00 EET | Press release

SES and SpeQtral signed a Memorandum of Understanding (MoU) to develop an interoperable Optical Ground Station (OGS) to establish long-distance satellite-based Quantum Key Distribution (QKD) between Asia and Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250328851677/en/ SES's CEO Adel Al-Saleh and SpeQtral's CEO Chune Yang Lum sign a Memorandum of Understanding to develop an interoperable Optical Ground Station to establish long-distance satellite-based Quantum Key Distribution between Asia and Europe. Under the agreement, the development of an interoperable OGS will enable SES and SpeQtral to connect both companies’ current and future QKD satellite missions, resulting in easier access to, and diversity in the supply of long-distance QKD to end users in Asia, Europe and other future compatible ground stations worldwide. The integration of this proposed OGS with Singapore’s fibre-QKD network will help future customer

SBC Medical Group Holdings Inc. Announces Fourth Quarter and Full Year 2024 Financial Results28.3.2025 13:00:00 EET | Press release

SBC Medical Group Holdings Incorporated (NASDAQ: SBC, “SBC Medical” or the “Company”), a global owner, operator and provider of management services and products to cosmetic treatment centers, today announced its financial results for -the three months ended December 31, 2024 and full year 2024. Fourth Quarter 2024 Highlights Total revenues were $44 million, representing a 29% year-over-year decrease. Gross profit was $34 million, representing a 22% year-over-year decrease. Income from operations was $5 million, representing an 80% year-over-year decrease. EBITDA1, which is calculated by adding depreciation and amortization expense and impairment loss to income from operations was $21 million, representing a 22% year-over-year decrease. EBITDA margin1was 47% for the fourth quarter of 2024, compared to 43% for the fourth quarter of 2023. Net income attributable to SBC Medical Group was $7 million, representing a 54% year-over-year decrease. Earnings per share, which is defined as net inc

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye